14 June 2013: Product Investigations
Antibacterial activity of selected commercial products for mouth washing and disinfection, assessed in accordance with PN-EN 1040
Stefan Tyski ADEG , Ewa Bocian BCDEF , Agnieszka Mikucka BD , Wanda Grzybowska CEF
DOI: 10.12659/MSM.883952
Med Sci Monit 2013; 19:458-466
Background
In the Polish market there is currently a broad range of products for mouth washing and disinfection. These products differ in qualitative and quantitative composition and in the concentration of active substances. In antisepsis and disinfection, the significant reduction in number of microorganism cells in a particular environment is crucial. The chemical agents should provide a significant degree of microorganism reduction in a relatively short time period.
The European Committee for Standardization (CEN) has been developing standards for evaluation of the effectiveness of antiseptics and disinfectants for many years. These standards allow standardization of analytical methods used in tests. The relevant EN standards (currently adopted as the Polish standards PN) allow comparison of antimicrobial activity of a number of products with the same application. Previously, this comparison was impossible due to the use of various, diverse procedures (different contact time, concentrations, and tested strains).
The purpose of this study was to examine the bactericidal activity of selected herbal products and other products for mouth washing, possessing antibacterial activity as declared by the manufacturers, used in treatment of inflammation and for disinfection of the mouth.
Material and Methods
A total of 28 products for mouth washing and disinfection, available in department stores and pharmacies, were included in this study. Their characteristics are presented in Table 1. Bactericidal activity was studied according to the PN-EN 1040 standard “Chemical disinfectants and antiseptics – Quantitative suspension test for the evaluation of basic bactericidal activity of chemical disinfectants and antiseptics - Test method and requirements (Phase 1)” [1]. It is assumed that the product possesses antibacterial properties if it causes minimum of 5 log reduction in the number of viable bacteria after 60 min or less, when the test organisms are
To perform the test, the densities of bacterial suspensions were adjusted to a value of 1.5–5×108 cfu/mL. Two contact times were used: 5 min and/or 60 min. At the end of the contact time, bactericidal activity was immediately neutralized by using neutralizer consisting of lecithin (AppliChem) – 3 g/L, Polysorbate 80 (POCH Gliwice) – 30 g/L, sodium thiosulfate (Sigma) – 5 g/L, L-histidine (Merck) – 1 g/L, saponin (Sigma) – 30 g/L, tryptone (Difco) – 1 g/L, NaCl (POCH Gliwice) – 8.5 g/L, and water – up to 1 L.
During this study, the dilution-neutralization method was applied. The test procedure was as follows: 1 mL of water and 1 mL of bacterial test suspension were added to 8 mL of the examined product test solution. At the end of the contact time, 5 or 60 min ±10 s, a 1-mL sample of the test mixture was transferred into a tube with 8 mL of neutralizer mixed with 1 mL of water. After 5 min ±10 s of neutralization time, a 1-mL sample of neutralized test mixture was immediately taken in duplicate and inoculated using the pour plate technique. The plates were incubated in 37±1°C. After 24 h, the number of colony-forming units (cfu) was determined. After 48 h of incubation, verification of the absence of toxicity of the neutralizer and validation of the dilution-neutralization method tests were performed at the same time and under the same conditions. Tests of antibacterial activity of products were performed in duplicate.
Results
An assessment of the effectiveness of the bactericidal activity in 2 contact times (5 and 60 min), was carried out on 4 herbal products listed in the Register of Medicinal Products authorized in Poland: Dentosept A, Salviae, Stomatosol, and Salviasept.
After conducting a preliminary study of the efficacy of Dentosept A, which was not diluted (concentration recommended by the manufacturer), a reduction in the number of bacterial cells within all tested strains required by the standard was noticed. In the case of 70% solution of this product, reduction in number of bacterial cells of 4 tested strains was about 5 log. However, this result occurred for
The bactericidal efficacy of the Salviae product based, on the preliminary studies, was insufficient at the concentration recommended by the manufacturer (approximately 2%). In accordance with PN-EN 1040, the product Salviae possesses bactericidal activity for all tested strains at a concentration of 30%. The analysis of the bactericidal activity of the product showed that a 10% solution was effective only against
Tests of the effectiveness of the Salviasept product showed that, in the dilution recommended by the manufacturer (1.6%), it meets the requirements of the PN-EN 1040 standard after 5 min only for the
Preliminary investigations of the Stomatosol product for mouth washing showed that this product, in concentrations recommended by the manufacturer (approx. 4%), did not possess bactericidal activity meeting the standard, but when the product was used in undiluted form, the requirements of PN-EN 1040 were met after just 5 min. Analysis of the bactericidal activity of a 10% concentration of Stomatosol showed a reduction in the number of viable cells of
Due to the presence of ethanol in the tested herbal products, the antibacterial activity of ethyl alcohol at concentrations of 10–50% was conducted on 4 bacterial strains at 2 contact times: 5 and 60 min. A 5 log reduction in the number of bacterial cells was achieved for all tested strains after 5 min contact time for 50% ethanol. Ethanol at a 40% concentration only completely eliminated
It was observed that ethanol concentrations of 30% and lower did not show any bactericidal activity against the tested strains. The survey revealed that antimicrobial activity of ethanol can be excluded in the Stomatosol, Salviae, and Salviasept products at concentrations of 50% and lower.
Two other products from the group of medicinal products – Corsodyl and Hascosept – at the level of 5 log bactericidal activity against all tested strains after 5 min of contact time. Undiluted products were tested according to manufacturers’ recommendations.
Studies of the effectiveness of 22 different products for mouth washing, commonly available in department stores and pharmacies, were performed against 4 test strains using 2 contact times: 5 and 60 min. These products, according to manufacturer’s recommendations, were undiluted while tested.
Study of the effectiveness of Mouthwash with fluoride, Elgydium, Paroplak, and Sensikin against 4 bacterial strains showed that they failed to achieve a 5 log reduction the number of viable bacteria, even after 1 h of contact time. The product ‘Mouthwash with fluoride’ was used as a control because the manufacturer has not declared any antibacterial activity.
A 5 log reduction in the number of bacterial cells for all tested strains after 5 min of contact time was proven for the following products: Aquafresh, Eludril, Listerine Freshmint, Listerine Cleanmint, Oral B Advantage Mouth Rinse, Denivit, Active Oral Care Extra Strength Original, Cepacol ‘Antibacterial Mouthwash with Ceepryn’, and Walgreens Fresh Breath Antiseptic Mouth Rinse.
In the study of the effectiveness of the products Mouthwash antiseptic and Elmex, reduction in the number of
The evaluation of the efficacy of the Hascosept, Protefix Dental Antisept, and Oreksyd products showed bactericidal activity in accordance with PN-EN 1040 standard against the tested microorganisms after 5 min and after 60 min, only in the case of
Meridol and Lacalut Aktiv were effective against
Studies of the bactericidal activity of Orthokin did not show enough efficacy against
In the case of Pearl Drops, the effectiveness of the bactericidal activity against
Figure 1 illustrates the antibacterial effectiveness of the products used for mouth hygiene and disinfection. A total of 13 out of 27 products (48%), including 3 medicinal products, demonstrated bactericidal activity against all tested strains in accordance with the standard. Up to 19% of the products, including 2 medicinal products, did not demonstrate bactericidal activity against any of the tested strains according to PN-EN 1040. One-third of the tested products caused the reduction of bacterial cells required by PN-EN 1040, but only in 1–3 strains.
Discussion
The information provided by manufacturers on the packaging or in the leaflets of products for mouthwash and disinfection is important for consumers. The manufacturers of antiseptic products should provide data on the concentration, duration of application, and scope of the antimicrobial activity.
Our study investigated whether the common, commercially available medicinal products and cosmetics meet the current, basic bactericidal requirements of the PN-EN 1040 standard for chemical disinfectants and antiseptics.
It was assumed that a product intended for use as an oral antiseptic is effective when the reduction of bacterial cells is on the level of at least 5 log after 5 min of contact time, which corresponds with the standard and is actually a reasonable mouth washing time. The mouth washing time can be shorter, however, when washing with water is not done, as a substantial amount of the product remains on the mouth mucosa for some time and allows the antibacterial effect to last longer. Antibacterial activity was also studied after 60 min of contact time, as it is the longest time specified by the standard PN-EN 1040 for disinfectants and antiseptics.
International, standardized test methods for evaluation of antimicrobial activity of preparations for oral cavity disinfection do not exist. Thus, researchers generally use different bacterial strains (ie, clinical isolates) and different assay conditions to evaluate antibacterial activity of mouth disinfectants. Results obtained this way are impossible to compare.
The European Committee for Standardization (CEN) has created several European Standards for evaluation of antimicrobial activity of chemical disinfectants and antiseptics. Standards concerning the test methods of Phase 1, for evaluation of basic antibacterial and antifungal activity (EN 1040, EN 1275), are aimed at general applications. There is no differentiation between antimicrobial requirements for antiseptic preparations applied on living tissue (skin and mucosa) and disinfectants used in order to diminish the microbial count on surfaces and instruments (medical devices). The CEN standards relate to only a limited range of microbial species and a limited number of standard strains. These have been chosen as representative, taking into consideration their relative resistance and their relevance to practical use. The CEN plans to evaluate the Phase 3 tests performed under practical conditions, with usage of clinical isolates; however, no single standard is available and only standard strains are recommended in the EN.
The oral microbes colonizing the surfaces of oral cavity mucosa, teeth, and tongue, as well as present in saliva, were not included in the study because of the diversity of strains. There are hundreds of species of oral bacteria, some of them pathogenic. These bacteria may be even more susceptible to the analyzed antiseptic preparations than standard strains recommended in the EN. However, CEN’s idea was to use resistant rather than susceptible strains in tests. The incorporation of oral microbes in tests may be more appropriate, taking into consideration the possibility of control of oral health problem by use of antiseptics, but the aim of our study was to use the international, standardized, CEN method dedicated for evaluation of antibacterial activity of antiseptics, and to compare this activity of the products for mouth washing and oral disinfection present on the Polish market.
This study involved 2 groups of products: 1) medicinal products containing herbal extracts used against infections and inflammation of the mucous membranes of the mouth and 2) popular, widely available, liquids (rinses) for oral hygiene.
Hayes et al. [3] claimed that the active ingredients (essential oils) are used in medicinal products and antiseptics because of their antimicrobial activity and because of a lack of resistance mechanisms to these substances. Antimicrobial activity of essential oils depends on their chemical composition and it is related to plant species, vegetative parts of the plant used, and phase of plant development, as well as soil and climate conditions. Shapiro et al. [4] showed a high efficacy of peppermint, sage, and tea tree oils, thymol and eugenol, against bacteria colonization of the mouth. Adams and Kunz [5] proved that essential oils, due to their lipophilic properties, damaged the cell walls and cytoplasmic membranes of bacteria and fungi, leading to the leakage of cytoplasm. These oils inhibited the synthesis of DNA, RNA, proteins, and polysaccharides, as well as enzymatic activity. Antimicrobial activity of essential oils is determined by the activity of individual components. The synergistic effect of essential oils components that influence biocidal action is often observed.
Kalemba [6] studied essential oils derived from plants in our climate zone, such as thyme, rosemary, yarrow, mint, sage, and clove. He showed that each of these essential oils possesses antimicrobial activity against at least 1 organism, and the efficacy increases with oil concentration. Takarada et al. [7] studied the susceptibility of pathogenic bacteria to various antiseptics used in the mouth, and proved that tea tree and eucalyptus oils were biocidal to bacteria that cause paradontosis and dental caries. It was shown that a 0.2% solution of essential oils kills
After 5 min of contact time, the Salviae product in 40% concentration (approximately 28% ethanol) and the Salviasept product in 20% concentration (approximately 10% ethanol) showed reduction of bacteria as required by the standard. The Stomatosol product in 20% concentration (approximately 14% ethanol) was active after only 60 min of contact time. Control tests showed that such ethanol concentrations did not exhibit any antimicrobial activity. This study suggests the use of higher concentrations of plant extracts in products for mouth antisepsis than is recommended by the manufacturers.
The second group of products tested in this study was commercially available mouthwashes with antibacterial activity declared by the manufacturers. Two out of 23 of these products are included in the Register of Medicinal Products in Poland, and 16 out of 23 are included in the Central Register of Cosmetics. Many of them contain alcohol or chlorhexidine, or both. Bocian and Tyski [10] reported that solutions of ethanol in 60–70% concentrations were the most effective against
In the present study, we demonstrated that Hascosept containing ethanol and benzydamine hydrochloride has antibacterial properties towards ¾ of tested microbial strains after 5 min contact time, but in the case of
Van Strydonk et al. [12] demonstrated the comparable efficacy of both preparations in reducing dental plaque. The products Aquafresh, Cepacol and Active Oral Care Extra Strength Original were proven to act as good oral antiseptics. Andre et al. [13] demonstrated bactericidal activity of Cepacol towards
The products Eludril and Denivit were found to be effective against tested microorganisms after 5 min. The product Protefix Dental Antisept required 60 min of contact time for 1 of the strains; this is a very long time and, therefore, not practical for an antiseptic mouth rinse. The product Paroplak has no adequate biocidal activity against any tested bacteria. Quirynem [16], who studied the effectiveness of chlorhexidine at 0.12% and 0.2% concentrations, achieved comparable reduction in the number of bacteria: 78% and 89%, respectively. Despite the best results being observed for concentrations of 0.2%, the obtained difference was not statistically significant. The author suggests the possibility of reducing chlorhexidine concentrations without a significantly negative influence on therapeutic effect. Clinical studies performed with 0.12% chlorhexidine solution showed an 81–90% reduction of tongue microflora and 89–95% reduction of saliva microorganisms [17,18]. The products for mouth washing containing 0.2% chlorhexidine are recommended for the control of dental plaque and for the support of periodontitis treatment [19,20]. Gos-Slomka [21] conducted research at the Centre for Pediatric Pulmonology in Karpacz and showed a significant efficacy of the product Corsodyl (chlorhexidine gluconate 0.2%) in reducing the amount of dental plaque and reducing gingivitis. This decrease was noticeable most clearly for children aged 8–12 years, after the first 3 days of washing. A significant improvement in gingivitis was obtained both by decline in the amount of dental plaque as a major etiological agent of gingivitis and by the antibacterial activity of Corsodyl.
Limited studies of antimicrobial activity according to custom methods on products containing chlorhexidine, benzydamine, salvia, and gel with polyvinylpyrrolidone-sodium hyaluronate were carried out using microbial strains colonizing the oral cavity –
Luc et al. [23] studied biocidal activity of Corsodyl using the dilution-neutralization method. They observed efficacy against
This observation confirms that this product has a bactericidal activity only against certain microorganisms. The studies of Luc et al. [23] described earlier showed that the product Lacalut was not an effective antiseptic. The results in this publications show that the rinse was effective against
References
1.
2.
3. Hayes AJ, Leach DN, Markham JL, Markowic B: Oil Res, 1997; 9; 575-82
4. Shapiro S, Meier A, Guggenheim B, The antimicrobial activity of essential oils and essentials oil components towards oral bacteria: Oral Microbiol Immunol, 1994; 9; 202-8, pmid: 7478759
5. Adams S, Kunz B, Mycelial deformations of Cladosporium herbarum due to the application of eugenol or carvacrol: J Essen Oil Res, 1996; 8; 535-45
6. Kalemba D, Chemical composition of the essential oil of Larix decidua Mill: ssp Advances in Microbiology, 1999; 38; 185-203
7. Takarada K, Kimizuka R, Takahaski N, A comparison of the antibacterial efficacies of essentials oils against oral pathogenes: Oral Microbiol Immunol, 2004; 19; 61-64, pmid: 14678476
8. Hammer KA, Dry L, Jahnson M: Microbiol Immunol, 2003; 18; 389-92
9. Kedzia A, Application of Dentosept preparation toward anaerobe bacteria isolated from gingival pockets: Czas Stomat, 2000; 8; 479-84
10. Bocian E, Tyski S, Application of alcohols in antiseptic procedures: Zakazenia, 2003; 3; 68-74
11. Rotter ML, Alcohols for antisepsis of hands and skin: Handbook of Disinfectants and Antiseptics, 1996; 177-233, New York, Marcel Dekker Inc
12. van Strydonck DA, Timmerman MF, van der Velden U, van der Weijden GA, Plaque inhibition of two commercially avaible chlorhexidine mouthrinses: J Clin Periodontol, 2005; 32; 305-9, pmid: 15766375
13. Andre RF, Andrade IM, Silva-Lovato CH, Prevalance of mutans streptococci isolated from complete dentures and their susceptibility to mouthrinses: Braz Dent J, 2011; 22; 62-67, pmid: 21519651
14. Bocian E, Tyski S, Chlorhexidine – one of the widely use antiseptics – Chemical and biological properties (Part I): Zakazenia, 2010; 2; 6-13
15. Bocian E, Tyski S, Chlorhexidine – one of the widely use antiseptics – Application of chlorhexidine preparations (Part II): Zakazenia, 2010; 4; 7-19
16. Quirynem M: J Clin Periodontol, 2001; 28; 1127, pmid: 11737510
17. Sreenivasan PK, Gittins E, The effects of a chlorhexidine mouthrinse on culturable microorganisms of the tongue and saliva: Microbiol Res, 2004; 159; 365-70, pmid: 15646383
18. Scannapieco FA, Yu J, Raghavendram K, A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients: Crit Care, 2009; 13; R117, pmid: 19765321
19. Malicka B, Zietek M, Grzebieluch W, Application of chlorhexidine in dentistry: Dent Med Probl, 2005; 42; 497-505
20. Milstone AM, Passaretti CL, Perl TM, Chlorhexidine: expanding the armamentarium for infection control and prevention: Clin Infect Dis, 2008; 46; 274-81, pmid: 18171263
21. Gos-Slomka M, Clinical evaluation of antiseptic preparation Corsodyl efficiency in improvement of oral cavity hygiene among children: Przeglad Stomatologii Wieku Rozwojowego, 1999; 1; 35-38
22. Vokurka S, Skardova J, Hruskova R, Kabatova-Maxova K, The effect of polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair) on oral microbial colonization and pain control compared with other washing solutions in patients with oral mucositis after allogeneic stem cells transplantation: Med Sci Monit, 2011; 17(10); CR572-76, pmid: 21959611
23. Luc J, Dybizbanska E, Roques Ch: Nowa Stomatologia, 2004; 4; 181-84
24. Chen Y, Wong RW, Seneviratne CJ: Am J Orthod Dentofacial Orthop, 2011; 140; 537-42, pmid: 21967942
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






